• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[β3肾上腺素能受体基因多态性与肥胖]

[Beta 3 adrenergic receptor polymorphism and obesity].

作者信息

Yoshida T, Umekawa T

机构信息

First Department of Internal Medicine, Kyoto Prefectural University of Medicine.

出版信息

Nihon Rinsho. 1998 Jul;56(7):1871-5.

PMID:9702068
Abstract

The beta 3-adrenoceptor plays a significant role in the control of lipolysis and thermogenesis in the brown adipose tissue of rodents and humans. In human beta 3-adrenoceptor, a Trp to Arg replacement has recently been discovered. This change which occurs at position 64, in the first coding exon, has been correlated with increased weight gain, difficulty in losing weight, insulin resistance syndrome, and worsened diabetic situation. Higher percentages of this mutation are observed in Pima Indians (over 30%) and Japanese (20%). The possible functional mechanism of Trp54Arg is reported using human HEK293 cell line stably expressing the wild type and the [Arg64] beta 3-adrenoceptor type. Beta 3-adrenoceptor agonists available for humans are been also developing. In this paper we describe these points up-to-date.

摘要

β3肾上腺素能受体在啮齿动物和人类棕色脂肪组织的脂肪分解和产热控制中发挥着重要作用。在人类β3肾上腺素能受体中,最近发现了色氨酸到精氨酸的替换。这种发生在第一个编码外显子第64位的变化与体重增加、减肥困难、胰岛素抵抗综合征以及糖尿病病情恶化有关。在皮马印第安人(超过30%)和日本人(20%)中观察到这种突变的比例更高。使用稳定表达野生型和[Arg64]β3肾上腺素能受体类型的人HEK293细胞系报道了Trp54Arg的可能功能机制。可供人类使用的β3肾上腺素能受体激动剂也在研发中。在本文中,我们将对这些要点进行最新描述。

相似文献

1
[Beta 3 adrenergic receptor polymorphism and obesity].[β3肾上腺素能受体基因多态性与肥胖]
Nihon Rinsho. 1998 Jul;56(7):1871-5.
2
[Insulin resistance and beta 3-adrenergic receptor function].[胰岛素抵抗与β3-肾上腺素能受体功能]
Nihon Rinsho. 2000 Feb;58(2):333-7.
3
Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an update.用于治疗肥胖症和糖尿病的β3-肾上腺素能受体激动剂的研发进展——最新情况
Diabetes Metab. 1999 Mar;25(1):11-21.
4
[Beta-3 adrenergic receptor--structure and role in obesity and metabolic disorders].[β-3肾上腺素能受体——在肥胖和代谢紊乱中的结构与作用]
Postepy Hig Med Dosw. 1999;53(5):705-15.
5
Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene.非胰岛素依赖型糖尿病的发病时间与β3-肾上腺素能受体基因的遗传变异
N Engl J Med. 1995 Aug 10;333(6):343-7. doi: 10.1056/NEJM199508103330603.
6
[The role of beta 3-adrenergic receptors in the human organism].
Przegl Lek. 2001;58(7-8):788-91.
7
[The adrenergic beta-3 receptor: a role in the genetic predisposition to obesity and diabetes?].
Rev Med Liege. 1997 Nov;52(11):703-8.
8
Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity.β3 - 肾上腺素能受体的基因变异与病态肥胖患者体重增加能力增强。
N Engl J Med. 1995 Aug 10;333(6):352-4. doi: 10.1056/NEJM199508103330605.
9
No effect of the Trp64Arg beta 3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue.色氨酸64精氨酸β3 -肾上腺素能受体变体对皮下脂肪组织体内脂肪分解无影响。
Diabetologia. 1997 Jul;40(7):838-42. doi: 10.1007/s001250050757.
10
[Beta 3-adrenergic receptor].[β3肾上腺素能受体]
Tanpakushitsu Kakusan Koso. 2000 Apr;45(6 Suppl):935-40.

引用本文的文献

1
Regulation of gene expression by FSP27 in white and brown adipose tissue.FSP27 对白色和棕色脂肪组织中基因表达的调控。
BMC Genomics. 2010 Jul 22;11:446. doi: 10.1186/1471-2164-11-446.
2
The contribution of psychosocial stress to the obesity epidemic: an evolutionary approach.心理社会压力对肥胖流行的影响:一种进化视角。
Horm Metab Res. 2009 Apr;41(4):261-70. doi: 10.1055/s-0028-1119377. Epub 2009 Jan 20.